SHA:600867 Market Cap

SHA:600867 has a market cap or net worth of 16.66 billion as of February 2, 2026. Its market cap has increased by 10.86% in one year.

Market Cap

16.66B

Enterprise Value

15.79B

Revenue

2.74B

Ranking

n/a

PE Ratio

13.67

Stock Price

8.60

Market Cap Chart

Since February 15, 2001, SHA:600867's market cap has increased from 3.86B to 16.66B, an increase of 331.33%. That is a compound annual growth rate of 6.03%.

Market Cap History

Date	Market Cap	% Change
Feb 2, 2026	16.66B	4.90%
Dec 31, 2025	15.88B	1.06%
Dec 31, 2024	15.71B	-26.86%
Dec 29, 2023	21.48B	17.97%
Dec 30, 2022	18.21B	-17.83%
Dec 31, 2021	22.16B	-17.92%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Betta Pharmaceuticals	19.80B
China Resources Double-Crane Pharmaceutical	19.37B
Shandong Buchang Pharmaceuticals	17.94B
Shenzhen Kangtai Biological Products	17.46B
Hybio Pharmaceutical	16.70B
Shenzhen Hepalink Pharmaceutical Group	16.51B
Guangdong Zhongsheng Pharmaceutical	16.28B
Zhejiang Jiuzhou Pharmaceutical	16.08B

Market Cap Rankings